BACKGROUND Nonrandomized studies have reported focal impulse and rotor modulation (FIRM)-guided ablation to be superior to pulmonary vein antrum isolation (PVAI) for persistent atrial fibrillation and long-standing persistent atrial fibrillation.
T he low efficacy of medical therapy in maintaining sinus rhythm and the plethora of side effects associated with those drugs have prompted the search for new techniques and technologies to optimize the catheter ablation procedure for the treatment of atrial fibrillation (AF) (1) .
Pulmonary vein antrum isolation (PVAI) is still the cornerstone for AF ablation in paroxysmal AF patients, with reported success rates as high as 80% (2) . However in persistent atrial fibrillation (PeAF) and long-standing persistent atrial fibrillation (LSPAF), the success rate is much lower even with repeat procedures (3) . A potential reason behind this poor outcome is lack of information on the optimal ablation technique and the best targets to achieve freedom from arrhythmia (4) . PeAF and LSPAF are chronic diseases associated with progressive atrial fibrosis and evolving pulmonary and nonpulmonary vein (non-PV) triggers (2) . It is unclear whether substrate ablation alone, the elimination of triggers of AF, or a combination of both is the ideal ablation approach in this subset of AF population (4) . This uncertainty is compounded by findings from the recently completed STAR-AF II (Substrate and Trigger Ablation for Reduction of Atrial Fibrillation II) trial, which failed to observe any reduction in the rate of recurrent AF when additional linear ablation or ablation of complex fractionated electrograms were performed along with PVI in PeAF patients (5) . Of the many emerging approaches to modify AF-sustaining substrate, a promising strategy is the focal impulse and rotor modulation (FIRM)-guided ablation that targets electrical rotors and focal sources that are believed to be responsible for perpetuation of AF (6, 7) . Some trials have reported improved success rate with rotor ablation alone or in combination with PVAI versus PVAI alone, but none of these studies were randomized (7) (8) (9) . We designed a pro- 
RANDOMIZATION.
A central computerized randomization scheme was generated using block randomization, and sets of randomly selected blocks were provided to the investigating sites. To maintain allocation concealment, the site administrators were instructed not to reveal the arm assignment until the subject's eligibility was verified and the subject was ready to be randomized.
ENDPOINT. The primary endpoint was single procedure freedom from any recurrent AF/atrial flutter/ atrial tachycardia (AT) while off antiarrhythmic drugs. Recurrence was defined as atrial arrhythmia (AF, atrial flutter, or AT) of >30 s duration while off antiarrhythmic drugs at follow-up. Any episodes that occurred during the first 60 days (blanking period) after the procedure were not considered a recurrence.
Secondary endpoints included acute procedural success and periprocedural complications. Acute procedural success was defined as AF termination, $10% slowing, or organization into AT.
DEFINITIONS. Electrical rotors were defined as sustained clockwise or counterclockwise activation around a core (6, 8) . Focal impulses were centrifugal activation from an origin (8) . Non-PV triggers were ectopic triggers originating from sites other than PV, Impact of Rotor Ablation in Nonparoxysmal AF Patients 275 contractions $10 beats/min with earliest activation from non-PV sites were targeted for ablation (10) .
Acute procedural success was defined as AF termination, $10% slowing, or organization into AT (Online Figures 1A to 1D ). ABLATION PROCEDURE. Our mapping and ablation procedures have been described in detail in earlier publications (6, 11, 12) . Briefly, antiarrhythmic drugs, except amiodarone, were discontinued 3 to 5 days before the procedure; amiodarone was stopped at least 4 to 6 months prior to the ablation. All patients underwent ablation under general anesthesia and uninterrupted anticoagulation with warfarin or novel oral anticoagulants. PVAI was always preceded by rotor ablation in group 2. If AF persisted despite elimination of all rotors or converted into AT, the patient was cardioverted.
PVAI, PW, AND NON-PV TRIGGER ABLATION. The ablation procedure has been described in earlier publications from our group (11, 12) . Briefly, PVAI and electrical isolation of the LA PW were performed us- 
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Complete abolition of all PV potentials rather than decrease in the amplitudes was the endpoint and was confirmed by entrance block. If ablation was unsuccessful in terminating the arrhythmia, cardioversion was performed to restore sinus rhythm.
After stable sinus rhythm was achieved either during ablation or after cardioversion, isoproterenol 20 to 30 mg/min for 15 to 20 min was given to disclose any non-PV triggers and to look for acute PV reconnection. Mapping was done using the circular map- Procedural parameters are summarized in Table 2 .
After rotor ablation, acute success was achieved in 12 patients (41%) and 11 (26%) in groups 1 and 2.
respectively. 
DISCUSSION
To the best of our knowledge, this is the first randomized trial that compared the efficacy of FIRM ablation with or without PVAI versus PVAI þ PW þ non-PV trigger ablation in PeAF and LSPAF patients (Central Illustration). Our main findings were the following: 1) acute procedural success after targeting the FIRM-identified rotors was achieved in a small number of patients-41% and 26% in group 1 and 2, respectively; 2) rotor-only ablation had very poor outcome in terms of arrhythmia recurrence for which that arm was terminated prematurely; and 3) PVAI plus rotor ablation had significantly longer procedure time and lower efficacy than PVAI þ PW þ non-PV trigger ablation. Mohanty et al. 
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We observed a significantly longer procedure time with rotor ablation with or without PVAI in our study population, which was in agreement with some earlier trials (7, 14) and in disparity with others (15) .
This discrepancy can be due to detection of more is well known that acute termination is not an easy task to accomplish in this subset of AF population (18) . In accordance with our findings, 2 recently published single-center experiences (7, 19) , have reported similarly low acute procedural success in nonparoxysmal population. Other feasible reasons might be the small sample size, nonrandomized study design with possible bias in patient selection, and the learning-curve effect (6) .
In our study, acute success was achieved in higher numbers of patients in group 1 than in group 2.
However, no conclusions can be drawn from this observation, as the groups were unbalanced in terms of number of patients included in the analysis. Our results demonstrated the extensive approach of PVAI þ LA PW þ ablation of non-PV triggers to be the most effective ablation strategy in the STUDY LIMITATIONS. AF recurrence could have been underestimated as the patients were not constantly monitored, and we could have also missed some asymptomatic events. However, patients included in this study were symptomatic and were able to distinguish their AF symptoms. Also, in an earlier study conducted by our group, we did not observe significant differences in the captured arrhythmia events between the implantable loop recorder and conventional monitoring (34) . A lengthier follow-up would have provided a better comparison of the long-term outcome of PVAI þ rotors ablation versus PVAI þ LA PW þ non-PV triggers ablation, but historically, the success rate of the latter ablation approach has been similar after $2 years' follow-up (27) . Finally, the sample size is relatively small.
However, we could still detect a true effect that was statistically significant. Impact of Rotor Ablation in Nonparoxysmal AF Patients
CONCLUSIONS

